BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX)
CUSIP: 09058V103
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 251,185,504
- Total 13F shares
- 167,662,220
- Share change
- -5,340,291
- Total reported value
- $1,261,171,584
- Put/Call ratio
- 136%
- Price per share
- $7.52
- Number of holders
- 256
- Value change
- -$40,361,715
- Number of buys
- 100
- Number of sells
- 122
Quarterly Holders Quick Answers
What is CUSIP 09058V103?
CUSIP 09058V103 identifies BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 09058V103:
Top shareholders of BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
|
Company |
8.3%
|
20,915,971
|
$158,961,378 | — | 30 Sep 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
8.1%
|
20,306,596
|
$154,330,129 | — | 30 Sep 2024 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
4.7%
|
11,865,000
|
$90,174,000 | — | 30 Sep 2024 | |
| Kynam Capital Management, LP |
13F
|
Company |
3.6%
|
9,085,368
|
$69,048,797 | — | 30 Sep 2024 | |
| STATE STREET CORP |
13F
|
Company |
3.5%
|
8,849,588
|
$67,256,869 | — | 30 Sep 2024 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
3.2%
|
8,135,804
|
$61,832,110 | — | 30 Sep 2024 | |
| ALKEON CAPITAL MANAGEMENT LLC |
13F
|
Company |
2.8%
|
7,093,822
|
$53,913,047 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.9%
|
4,837,985
|
$36,775,797 | — | 30 Sep 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
1.9%
|
4,814,549
|
$36,590,573 | — | 30 Sep 2024 | |
| RP Management, LLC |
13F
|
Company |
1.5%
|
3,846,154
|
$29,230,770 | — | 30 Sep 2024 | |
| Rock Springs Capital Management LP |
13F
|
Company |
1.4%
|
3,622,358
|
$27,529,921 | — | 30 Sep 2024 | |
| Fisher Asset Management, LLC |
13F
|
Company |
1.3%
|
3,338,062
|
$25,369,270 | — | 30 Sep 2024 | |
| GW&K Investment Management, LLC |
13F
|
Company |
1.3%
|
3,277,600
|
$24,910,000 | — | 30 Sep 2024 | |
| Caligan Partners LP |
13F
|
Company |
1%
|
2,583,585
|
$19,635,246 | — | 30 Sep 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.92%
|
2,320,529
|
$17,636,020 | — | 30 Sep 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.9%
|
2,252,749
|
$17,122,000 | — | 30 Sep 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.87%
|
2,181,012
|
$16,575,691 | — | 30 Sep 2024 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
0.86%
|
2,163,743
|
$16,444,447 | — | 30 Sep 2024 | |
| FMR LLC |
13F
|
Company |
0.79%
|
1,988,389
|
$15,111,756 | — | 30 Sep 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.75%
|
1,887,994
|
$14,348,754 | — | 30 Sep 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.74%
|
1,860,925
|
$14,143,030 | — | 30 Sep 2024 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.73%
|
1,843,289
|
$14,008,996 | — | 30 Sep 2024 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.71%
|
1,792,908
|
$13,626,101 | — | 30 Sep 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.71%
|
1,772,501
|
$13,471,008 | — | 30 Sep 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.7%
|
1,760,808
|
$13,382,141 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.69%
|
1,739,080
|
$13,217,014 | — | 30 Sep 2024 | |
| SEGALL BRYANT & HAMILL, LLC |
13F
|
Company |
0.59%
|
1,490,376
|
$11,326,858 | — | 30 Sep 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.53%
|
1,322,900
|
$10,054,040 | — | 30 Sep 2024 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.48%
|
1,194,059
|
$9,074,848 | — | 30 Sep 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.46%
|
1,160,965
|
$8,823,336 | — | 30 Sep 2024 | |
| JUPITER ASSET MANAGEMENT LTD |
13F
|
Company |
0.43%
|
1,069,899
|
$8,131,232 | — | 30 Sep 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.4%
|
1,005,108
|
$7,638,821 | — | 30 Sep 2024 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.36%
|
892,430
|
$6,782,468 | — | 30 Sep 2024 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.35%
|
883,817
|
$6,717,009 | — | 30 Sep 2024 | |
| Trexquant Investment LP |
13F
|
Company |
0.35%
|
880,991
|
$6,695,532 | — | 30 Sep 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.32%
|
800,000
|
$6,080,000 | — | 30 Sep 2024 | |
| Cutter Capital Management, LP |
13F
|
Company |
0.32%
|
798,137
|
$6,065,841 | — | 30 Sep 2024 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.31%
|
787,227
|
$5,982,926 | — | 30 Sep 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.28%
|
711,425
|
$5,406,830 | — | 30 Sep 2024 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.27%
|
682,324
|
$5,185,662 | — | 30 Sep 2024 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.27%
|
676,292
|
$5,139,819 | — | 30 Sep 2024 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.27%
|
667,000
|
$5,069,200 | — | 30 Sep 2024 | |
| NORGES BANK |
13F
|
Company |
0.24%
|
611,900
|
$4,650,440 | — | 30 Sep 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.24%
|
596,838
|
$4,535,970 | — | 30 Sep 2024 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.24%
|
593,466
|
$4,510,341 | — | 30 Sep 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.23%
|
589,080
|
$4,477,008 | — | 30 Sep 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.23%
|
577,129
|
$4,386,180 | — | 30 Sep 2024 | |
| ORACLE INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.21%
|
535,558
|
$4,070,241 | — | 30 Sep 2024 | |
| Eversept Partners, LP |
13F
|
Company |
0.21%
|
535,405
|
$4,069,078 | — | 30 Sep 2024 | |
| PDT Partners, LLC |
13F
|
Company |
0.21%
|
522,280
|
$3,969,328 | — | 30 Sep 2024 |
Institutional Holders of BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX) as of Q4 2024
As of 31 Dec 2024,
BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX) was held by
256 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
167,662,220 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, Avoro Capital Advisors LLC, Kynam Capital Management, LP, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), STATE STREET CORP, ALKEON CAPITAL MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, RP Management, LLC, and Nuveen Asset Management, LLC.
This page lists
256
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
255
Q4 2024 holders
256
Holder diff
1
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.